Retrospective Study
Copyright ©The Author(s) 2024.
World J Clin Cases. Jul 6, 2024; 12(19): 3776-3784
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3776
Table 1 Comparison of general information
Group
Case
Sex (male/female)
Age (yr)
Course of illness (d)
Hemiplegic side: Left right
Lesion nature (cade): Cerebral infarction cerebral hemorrhage
Control group5031/1961.10 ± 8.656.16 ± 1.6829 2132 18
Observation group530/2061.28 ± 9.726.42 ± 2.0326 2430 20
Table 2 Comparison of Fugl–Meyer Assessment-Upper Extremity scores before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group5028.60 ± 3.1736.92 ± 2.77a13.96< 0.05
Observation group5029.26 ± 3.0740.54 ± 2.89a,b19.39< 0.05
F1.06551.0045
P value> 0.05< 0.05
Table 3 Comparison of Wolf Motor Function Rating Scale scores before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group5031.54 ± 2.9146.14 ± 3.04a24.52< 0.05
Observation group5031.08 ± 2.9253.10 ± 2.68a,b39.32< 0.05
F0.9970.7764
P value> 0.05< 0.05
Table 4 Comparison of modified Barthel Index values before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group5041.10 ± 7.0168.60 ± 7.28a19.21
21.17
< 0.05
Observation group5040.30 ± 5.8372.10 ± 8.86a,b< 0.05
F1.441.48
P value> 0.05< 0.05
Table 5 Comparison of Canadian Occupational Performance Measure scores before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group503.04 ± 0.644.32 ± 0.53a10.92
10.44
< 0.05
Observation group503.11 ± 0.784.91 ± 0.94a,b< 0.05
F0.600.32
P value> 0.05< 0.05
Table 6 Comparison of Canadian Occupational Performance Measure – Functional Mobility and Satisfaction before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group502.70 ± 0.744.92 ± 0.61a16.44< 0.05
Observation group502.73 ± 0.796.44 ± 1.21a,b16.69< 0.05
F0.870.32
P value> 0.05< 0.05
Table 7 Comparison of Short-Form 36-Item Health Survey scores before and after treatment
Group
Case (n)
Before treatment
After treatment
t value
P value
Control group50
50
46.37 ± 3.0469.10 ± 10.72a−14.91
−54.67
< 0.01
Observation group47.48 ± 4.1587.58 ± 3.46a,b< 0.01
F1.5311.61
P value> 0.05< 0.01
Table 8 Comparison of clinical efficacy, cases (%)
Group
Case (n)
Significant effect
Effective
Invalid
Total effectiveness
Control group501428884
Observation group503512394a